Array to buy rights to encorafenib By: MarketMinute.com Stock News January 23, 2015 at 11:37 AM EST Array BioPharma Inc. (Nasdaq: ARRY) will acquire the worldwide rights to encorafenib from Novartis. The stock price soared $1.87 to $6.92. Related Stocks: Array Technologies Inc